Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease.
Miyao K, Murata M, Nishida T, Ozawa Y, Uchida N, Fukuda T, Doki N, Eto T, Kawakita T, Mori Y, Takada S, Ohigashi H, Tanaka M, Kanda Y, Matsuoka KI, Ishimaru F, Atsuta Y, Kanda J, Terakura S; GVHD Working Group of the Japanese Society for Transplantation and Cellular Therapy. Miyao K, et al. Among authors: ohigashi h. Int J Hematol. 2024 Nov 14. doi: 10.1007/s12185-024-03871-4. Online ahead of print. Int J Hematol. 2024. PMID: 39543007
Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation.
Tamaki M, Kawamura S, Takano K, Nakamae H, Doki N, Ohigashi H, Maruyama Y, Ota S, Hiramoto N, Eto T, Yoshihara S, Matsuoka KI, Masuko M, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Yanagisawa R, Yakushijin K, Nakasone H. Tamaki M, et al. Among authors: ohigashi h. Cytotherapy. 2024 Oct 5:S1465-3249(24)00886-7. doi: 10.1016/j.jcyt.2024.09.007. Online ahead of print. Cytotherapy. 2024. PMID: 39453336
Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphoma.
Yoshimitsu M, Tanaka T, Nakano N, Kato K, Muranushi H, Tokunaga M, Ito A, Ishikawa J, Eto T, Morishima S, Kawakita T, Itonaga H, Uchida N, Tanaka M, Akizuki K, Ishitsuka K, Ohigashi H, Ota S, Ando T, Kanda Y, Fukuda T, Atsuta Y, Fuji S; ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy. Yoshimitsu M, et al. Among authors: ohigashi h. Br J Haematol. 2024 Oct 19. doi: 10.1111/bjh.19835. Online ahead of print. Br J Haematol. 2024. PMID: 39425565
Reduced-intensity conditioning with fludarabine/busulfan versus fludarabine/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation.
Kamijo K, Shimomura Y, Kim SW, Ohigashi H, Ishikawa J, Eto T, Hiramoto N, Mizuno I, Iida S, Ueda Y, Matsuoka KI, Yakushijin K, Mori Y, Onizuka M, Fukuda T, Atsuta Y, Kako S. Kamijo K, et al. Among authors: ohigashi h. Br J Haematol. 2024 Sep;205(3):1097-1107. doi: 10.1111/bjh.19651. Epub 2024 Jul 24. Br J Haematol. 2024. PMID: 39049594
Associations between acute and chronic graft-versus-host disease.
Tamaki M, Akahoshi Y, Inamoto Y, Morita K, Uchida N, Doki N, Tanaka M, Nishida T, Ohigashi H, Nakamae H, Onizuka M, Katayama Y, Matsuoka KI, Sawa M, Ishimaru F, Kanda Y, Fukuda T, Atsuta Y, Terakura S, Kanda J. Tamaki M, et al. Among authors: ohigashi h. Blood Adv. 2024 Aug 27;8(16):4250-4261. doi: 10.1182/bloodadvances.2024013442. Blood Adv. 2024. PMID: 38985337 Free PMC article.
Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide.
Ido K, Nakamae H, Hattori N, Kanaya M, Morita K, Hino M, Ohigashi H, Fukuda T, Eto T, Nagafuji K, Hiramoto N, Maruyama Y, Ota S, Matsuoka KI, Ando T, Akasaka T, Mori Y, Kamimura T, Kawakita T, Kawamura K, Kanda J, Onizuka M, Atsuta Y, Murata M. Ido K, et al. Among authors: ohigashi h. Br J Haematol. 2024 Sep;205(3):1077-1096. doi: 10.1111/bjh.19630. Epub 2024 Jul 7. Br J Haematol. 2024. PMID: 38972374
Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT.
Kawamura S, Tamaki M, Konuma T, Onizuka M, Sakaida E, Hayashi H, Doki N, Nishida T, Sawa M, Ohigashi H, Fukuda T, Ishikawa J, Matsuoka KI, Kawakita T, Tanaka M, Ishimaru F, Ichinohe T, Atsuta Y, Kanda Y, Yakushijin K, Kanda J, Nakasone H. Kawamura S, et al. Among authors: ohigashi h. Cytotherapy. 2024 Nov;26(11):1353-1361. doi: 10.1016/j.jcyt.2024.06.006. Epub 2024 Jun 12. Cytotherapy. 2024. PMID: 38958628
GVHD targets organoid-forming bile duct stem cells in a TGF-β-dependent manner.
Hasegawa Y, Hashimoto D, Zhang Z, Miyajima T, Saito Y, Li W, Kikuchi R, Senjo H, Sekiguchi T, Tateno T, Chen X, Yokoyama E, Takahashi S, Ohigashi H, Ara T, Hayase E, Yokota I, Teshima T. Hasegawa Y, et al. Among authors: ohigashi h. Blood. 2024 Aug 22;144(8):904-913. doi: 10.1182/blood.2023023060. Blood. 2024. PMID: 38905638
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era.
Terao T, Matsuoka KI, Fuji S, Kawamura S, Toya T, Doki N, Uchida N, Tanaka M, Fukuda T, Sawa M, Ishikawa J, Nishida T, Ohigashi H, Maruyama Y, Fujiwara SI, Kanda Y, Ota S, Ishimaru F, Atsuta Y, Kanda J, Ogata M, Yakushijin K, Nakasone H. Terao T, et al. Among authors: ohigashi h. Bone Marrow Transplant. 2024 Sep;59(9):1224-1231. doi: 10.1038/s41409-024-02313-3. Epub 2024 May 25. Bone Marrow Transplant. 2024. PMID: 38796633
587 results